Valeria Camarda

1.2k citations

39 papers · 1.1k indexed · h-index 22

Cellular and Molecular Neuroscience top 5%
- Neuropeptides and Animal Physiology 24
Endocrine and Autonomic Systems top 5%
Pharmacology top 5%
- Apelin-related biomedical research 8
Endocrinology, Diabetes and Metabolism top 10%
- Hormonal Regulation and Hypertension 8
Cognitive Neuroscience top 10%
- Sleep and Wakefulness Research 9
Molecular Biology
- Receptor Mechanisms and Signaling 17
- Chemical Synthesis and Analysis 7
Surgery
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 13
Physiology
- Pain Mechanisms and Treatments 5

Co-authors: Girolamo Calò D. Regoli Remo Guerrini Severo Salvadori Anna Rizzi Erika Marzola Claudio Trapella Chiara Ruzza
Cited by: Cellular and Molecular Neuroscience Endocrine and Autonomic Systems Pharmacology
Journals: The FASEB Journal (1 paper)Journal of Medicinal Chemistry (5 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
Partner nations: Italy United Kingdom United States

In The Last Decade

Valeria Camarda

39 papers receiving 1.1k citations

Peers

Countries citing papers authored by Valeria Camarda

Since Specialization

Citations

This map shows the geographic impact of Valeria Camarda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valeria Camarda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valeria Camarda more than expected).

Fields of papers citing papers by Valeria Camarda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valeria Camarda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valeria Camarda. The network helps show where Valeria Camarda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Valeria Camarda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Valeria Camarda Line = papers co-authored together Valeria Camarda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Chimeric G Proteins in Fluorimetric Calcium Assays: Experience with Opioid Receptors Methods in molecular biology ·Valeria Camarda,Girolamo Calò	2012	55
2	In vitro and in vivo pharmacological characterization of the novel NK1 receptor selective antagonist Netupitant Peptides ·Anna Rizzi,Barbara Campi,Valeria Camarda,Stefano Molinari,Sergio Cantoreggi,D. Regoli,Claudio Pietra,Girolamo Calò	2012	55
3	Synthesis and Separation of the Enantiomers of the Neuropeptide S Receptor Antagonist (9R/S)-3-Oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic Acid 4-Fluoro-benzylamide (SHA 68) Journal of Medicinal Chemistry ·Claudio Trapella,Michela Pelà,Luisa Del Zoppo,Girolamo Calò,Valeria Camarda,Chiara Ruzza,Alberto Cavazzini,Valentina Costa,V. Bertolasi,Rainer K. Reinscheid,Severo Salvadori,Remo Guerrini	2011	19
4	Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4) Peptides ·Mattia Volta,Matteo Marti,J. McDonald,Stefano Molinari,Valeria Camarda,Michela Pelà,Claudio Trapella,Michele Morari	2010	14
5	Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 Naunyn-Schmiedeberg s Archives of Pharmacology ·Valeria Camarda,Carmela Fischetti,Nicholas Anzellotti,Paola Molinari,Caterina Ambrosio,Evi Kostenis,D. Regoli,Claudio Trapella,Remo Guerrini,Severo Salvadori,Girolamo Calò	2009	59
6	Structure–activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide Bioorganic & Medicinal Chemistry ·Claudio Trapella,Carmela Fischetti,Michela Pelà,Ilaria Lazzari,Remo Guerrini,Girolamo Calò,Anna Rizzi,Valeria Camarda,David G. Lambert,John McDonald,D. Regoli,Severo Salvadori	2009	27
7	Structure–activity relationship study on Tyr9 of urotensin-II(4–11): Identification of a partial agonist of the UT receptor Peptides ·Madura Batuwangala,Valeria Camarda,John McDonald,Erika Marzola,David G. Lambert,Leong L. Ng,G. Calo',D. Regoli,Claudio Trapella,Remo Guerrini,Severo Salvadori	2009	9
8	Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol Brain Research Bulletin ·Engin Bojnik,Fruzsina Babos,Carmela Fischetti,Anna Magyar,Valeria Camarda,Anna Borsodi,S. Bajusz,Girolamo Calò,Sándor Benyhe	2009	2
9	Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 European Journal of Pharmacology ·Carmela Fischetti,Valeria Camarda,Anna Rizzi,Michela Pelà,Claudio Trapella,Remo Guerrini,John McDonald,David G. Lambert,Severo Salvadori,D. Regoli,Girolamo Calò	2009	31
10	The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems British Journal of Pharmacology ·David J. Behm,Gerald P. Stankus,Christopher Doe,Robert N. Willette,Henry M. Sarau,James J. Foley,Dulcie B. Schmidt,Parvathi Nuthulaganti,James A. Fornwald,Robert S. Ames,David G. Lambert,Girolamo Calò,Valeria Camarda,Nambi Aiyar,Stephen A. Douglas	2006	32
11	Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity Naunyn-Schmiedeberg s Archives of Pharmacology ·Wei Song,John E. McDonald,Valeria Camarda,Girolamo Calò,Remo Guerrini,Erika Marzola,Jonathan P. Thompson,David J. Rowbotham,David G. Lambert	2006	20
12	In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen⁵,DTrp⁷,Dab⁸]urotensin II(4–11) (UFP‐803) British Journal of Pharmacology ·Valeria Camarda,Martina Spagnol,Wei Song,Raffaella Vergura,Adelheid Roth,Jonathan P. Thompson,David J. Rowbotham,Remo Guerrini,Erika Marzola,Severo Salvadori,Paolo Cavanni,D. Regoli,Stephen A. Douglas,David G. Lambert,Girolamo Calò	2005	28
13	Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle European Journal of Pharmacology ·David J. Behm,Zhaohui Ao,Valeria Camarda,Nambi Aiyar,Douglas G. Johns,Stephen A. Douglas	2005	7
14	Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors European Journal of Pharmacology ·David J. Behm,Christopher L. Herold,Valeria Camarda,Nambi Aiyar,Stephen A. Douglas	2004	20
15	Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors European Journal of Pharmacology ·Valeria Camarda,Wei Song,Erika Marzola,Martina Spagnol,Remo Guerrini,Severo Salvadori,D. Regoli,Jonathan P. Thompson,David J. Rowbotham,David J. Behm,Stephen A. Douglas,Girolamo Calò,David G. Lambert	2004	51
16	[Arg14,Lys15]Nociceptin, a Highly Potent Agonist of the Nociceptin/Orphanin FQ Receptor: in Vitro and in Vivo Studies Journal of Pharmacology and Experimental Therapeutics ·Daniela Rizzi,Anna Rizzi,Raffaella Bigoni,Valeria Camarda,Giuliano Marzola,Remo Guerrini,Carmela De Risi,D. Regoli,Girolamo Calò	2002	45
17	In vitro and in vivo activity of analogues of the kinin B₂ receptor antagonist MEN11270 Canadian Journal of Physiology and Pharmacology ·Stefania Meini,Alessandro Lecci,F Carini,Manuela Tramontana,Sandro Giuliani,Carlo Alberto Maggi,Renzo Ricci,Giulia Fabbri,Beatrice Anichini,Nicholas J. S. Harmat,A. Rizzi,Valeria Camarda,D. Regoli,Laura Quartara	2002	2
18	Pharmacological characterisation of [(pX)Phe 4 ]nociceptin(1-13)amide analogues Naunyn-Schmiedeberg s Archives of Pharmacology ·Raffaella Bigoni,Daniela Rizzi,Anna Rizzi,Valeria Camarda,Remo Guerrini,David G. Lambert,Eiji Hashiba,Hartmut Berger,Severo Salvadori,D. Regoli,Girolamo Calò	2002	25
19	Pharmacological profile of hemokinin 1: a novel member of the tachykinin family Life Sciences ·Valeria Camarda,A. Rizzi,Girolamo Calò,Remo Guerrini,Severo Salvadori,D. Regoli	2002	48
20	A new ligand for the urotensin II receptor British Journal of Pharmacology ·Valeria Camarda,Remo Guerrini,Evi Kostenis,Anna Rizzi,Girolamo Calò,Almut Hattenberger,M. Zucchini,Severo Salvadori,D. Regoli	2002	47

About Valeria Camarda

Valeria Camarda is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems and Endocrinology, Diabetes and Metabolism, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (24 papers), Receptor Mechanisms and Signaling (17 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (13 papers), Sleep and Wakefulness Research (9 papers), Apelin-related biomedical research (8 papers), Hormonal Regulation and Hypertension (8 papers), Chemical Synthesis and Analysis (7 papers) and Pain Mechanisms and Treatments (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (600 citations), Endocrine and Autonomic Systems (123 citations) and Pharmacology (275 citations). Valeria Camarda has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Girolamo Calò, D. Regoli, Remo Guerrini, Severo Salvadori, Anna Rizzi, Erika Marzola, Claudio Trapella, Chiara Ruzza, Rainer K. Reinscheid and David G. Lambert. Their work appears in journals such as The FASEB Journal, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact